It was found that 88% of the tumor samples were Trx1-positive compared with only 8% of the ANTs and 80% of the sample were positive for TrxR1 positive, compared with only 24% of the ANTs (Fig. 1e). This evidence concerns the gene KMT2A and neoplasm.